CAS # 132-65-0
Categories*
Byproduct/Intermediate/Reactant
Medical/Veterinary/Research
Personal care product/Cosmetic ingredient
Unconventional Oil and Gas
Evidence Supporting This Chemical as an Endocrine Disruptor
Brinkmann M, Maletz S, Krauss M, Bluhm K, Schiwy S, Kuckelkorn J, Tiehm A, Brack W, Hollert H. 2014. Heterocyclic aromatic hydrocarbons show estrogenic activity upon metabolization in a recombinant transactivation assay. Environ Sci Technol 48(10):5892-5901.
Incardona JP, Collier TK, Scholz NL. 2004. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol 196(2):191-205.
Petersen K, Tollefsen KE. 2011. Assessing combined toxicity of estrogen receptor agonists in a primary culture of rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquat Toxicol 101(1):186-195.
*Category References
US FDA. 1990 Nov 7. Clean-Up of Ineffective Ingredients in OTC Drug Products.
US National Library of Medicine. Hazardous Substances Data Bank.
Zielinska B, Campbell D, Samburova V. 2014. Impact of emissions from natural gas production facilities on ambient air quality in the Barnett Shale area: a pilot study. J Air Waste Manag Assoc 64(12):1369-1383.